XOMA Royalty (XOMA) News Today $36.35 -0.81 (-2.18%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$36.33 -0.02 (-0.06%) As of 10/8/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock XOMA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Weiss Ratings Reiterates "Sell (D-)" Rating for XOMA Royalty (NASDAQ:XOMA)October 8 at 2:11 PM | marketbeat.comXOMA Royalty (NASDAQ:XOMA) Stock Crosses Above Two Hundred Day Moving Average - Time to Sell?October 7 at 4:56 AM | marketbeat.comXOMA Royalty PFD Update: Going Back To My Original Sell RatingsOctober 3, 2025 | seekingalpha.comXOMA Royalty PFD Update: Going Back To My Original Sell RatingsOctober 3, 2025 | seekingalpha.comXoma extends offer to acquire Lava TherapeuticsOctober 2, 2025 | msn.comLAVA Therapeutics Extends Tender Offer DeadlineOctober 2, 2025 | tipranks.comXOMA Royalty Corporation Extends Tender Offer for LAVA Therapeutics Shares Until October 17, 2025October 2, 2025 | quiverquant.comQXOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.October 2, 2025 | globenewswire.comLAVA Therapeutics Cancels Extraordinary General Meeting to Finalize XOMA Royalty Acquisition DetailsSeptember 30, 2025 | quiverquant.comQGoldman Sachs Group Inc. Sells 9,447 Shares of XOMA Royalty Corporation $XOMASeptember 29, 2025 | marketbeat.comEssa Pharma Agrees to Amend Terms to be Acquired by XenoTherapeuticsSeptember 24, 2025 | marketwatch.comESSA Pharma cuts shareholder payout in revised Xeno dealSeptember 24, 2025 | msn.comESSA Pharma Inc. Amends Agreement with XenoTherapeuticsSeptember 24, 2025 | prnewswire.comInsider Selling: XOMA Royalty (NASDAQ:XOMA) CFO Sells 4,330 Shares of StockSeptember 24, 2025 | insidertrades.comMural Oncology plc Publishes Definitive Proxy Statement for Acquisition by XOMA Royalty CorporationSeptember 23, 2025 | quiverquant.comQXOMA Royalty (NASDAQ:XOMA) CFO Sells $155,836.70 in StockSeptember 23, 2025 | marketbeat.comMural Oncology Plc Announces Acquisition by XOMA Royalty CorporationSeptember 23, 2025 | tipranks.comInsider Sale: SVP of $XOMA Sells 15 SharesSeptember 23, 2025 | quiverquant.comQXoma Completes Acquisition of HilleVaxSeptember 23, 2025 | tipranks.comXOMA Royalty Declares Quarterly Preferred Stock DividendsSeptember 22, 2025 | globenewswire.comXOMA Royalty (NASDAQ:XOMA) Stock Crosses Above 200 Day Moving Average - Here's WhySeptember 20, 2025 | marketbeat.comXoma announces closing of tender offer for HilleVaxSeptember 17, 2025 | msn.comHilleVax Acquired by XOMA, Delisting from NasdaqSeptember 17, 2025 | tipranks.comXOMA Royalty Corporation Completes Tender Offer for HilleVax, Inc. Shares and Merger FinalizedSeptember 17, 2025 | quiverquant.comQXOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.September 17, 2025 | globenewswire.comXOMA Royalty (NASDAQ:XOMA) Upgraded to Strong-Buy at Zacks ResearchSeptember 14, 2025 | marketbeat.comNuveen LLC Invests $286,000 in XOMA Royalty Corporation $XOMASeptember 8, 2025 | marketbeat.comXOMA Royalty Corporation $XOMA Shares Sold by BVF Inc. ILSeptember 5, 2025 | marketbeat.comXOMA Royalty Corporation Executives to Present Company Update at H.C. Wainwright 27th Annual Global Investment ConferenceSeptember 3, 2025 | quiverquant.comQXOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment ConferenceSeptember 3, 2025 | globenewswire.comQ3 EPS Estimates for XOMA Royalty Lifted by HC WainwrightAugust 26, 2025 | marketbeat.comHC Wainwright Predicts Stronger Earnings for XOMA RoyaltyAugust 24, 2025 | marketbeat.comXoma’s Strategic Acquisitions and Innovative Financial Strategies Drive Buy RatingAugust 22, 2025 | tipranks.comMural Oncology and XOMA Royalty Corporation Announce Definitive Agreement for Acquisition of Mural OncologyAugust 20, 2025 | quiverquant.comQMural Oncology to be acquired by XOMA unit for up to $2.24/share in cashAugust 20, 2025 | seekingalpha.comMural Oncology Enters Definitive Agreement for Acquisition by XOMA Royalty Corporation in Cash Deal Valued at Approximately $36.2 MillionAugust 20, 2025 | quiverquant.comQMural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per ShareAugust 20, 2025 | globenewswire.comQ3 EPS Estimates for XOMA Royalty Reduced by Leerink PartnrsAugust 19, 2025 | marketbeat.comLeerink Partnrs Raises Earnings Estimates for XOMA RoyaltyAugust 17, 2025 | marketbeat.comXOMA Royalty (NASDAQ:XOMA) Rating Increased to Hold at Zacks ResearchAugust 17, 2025 | marketbeat.comXOMA Royalty (NASDAQ:XOMA) Releases Earnings Results, Beats Estimates By $0.60 EPSAugust 16, 2025 | marketbeat.comXOMA Royalty Corporation Beat Analyst Profit Forecasts, And Analysts Have New EstimatesAugust 16, 2025 | finance.yahoo.comLAVA Therapeutics Announces Acquisition by XOMA CorporationAugust 14, 2025 | tipranks.comXoma Corp. Reports Strong Earnings Growth in 2025August 14, 2025 | msn.comLAVA Therapeutics Enters Agreement to Be Acquired by XOMA Royalty Corporation and Announces Discontinuation of LAVA-1266 DevelopmentAugust 13, 2025 | quiverquant.comQCautious Hold Rating on Xoma Amid Strategic Acquisitions and Uncertain Growth OutlookAugust 13, 2025 | tipranks.comXOMA Royalty Reports Second Quarter and Year to Date 2025 Financial Results and Highlights Recent Business AchievementsAugust 13, 2025 | globenewswire.comXOMA Royalty Corporation: XOMA Royalty Announces Closing of Tender Offer for Turnstone BiologicsAugust 11, 2025 | finanznachrichten.deXOMA Royalty Announces Closing of Tender Offer for Turnstone BiologicsAugust 11, 2025 | finance.yahoo.comXOMA Royalty (NASDAQ:XOMA) Upgraded to "Buy" at Wall Street ZenAugust 11, 2025 | marketbeat.com Get XOMA Royalty News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. XOMA Media Mentions By Week XOMA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XOMA News Sentiment▼0.210.63▲Average Medical News Sentiment XOMA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XOMA Articles This Week▼93▲XOMA Articles Average Week Get the Latest News and Ratings for XOMA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for XOMA Royalty and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies XOMA News MannKind News Celldex Therapeutics News Novavax News BioCryst Pharmaceuticals News OPKO Health News Dynavax Technologies News Innoviva News Zenas BioPharma News Geron News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XOMA) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XOMA Royalty Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share XOMA Royalty With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
